XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Share-based Payment Arrangement [Abstract] |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Stock-based compensation expense is included on the Condensed Consolidated Statements of Income and Comprehensive Income based upon the job function of the employees receiving the grants as follows (in millions):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Lease and Well | $ | 6 |  |  | $ | 11 |  |  | $ | 29 |  |  | $ | 36 |
Gathering and Processing Costs | 1 |  |  | 1 |  |  | 3 |  |  | 2 |
Exploration Costs | — |  |  | 4 |  |  | 10 |  |  | 15 |
General and Administrative | 27 |  |  | 35 |  |  | 57 |  |  | 64 |
Total | $ | 34 |  |  | $ | 51 |  |  | $ | 99 |  |  | $ | 117 |
Schedule of Weighted Average Fair Values and Valuation Assumptions | Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants during the nine-month periods ended September 30, 2022 and 2021 are as follows:
| Stock Options/SARs |  | ESPP
| Nine Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Weighted Average Fair Value of Grants | $ | 28.30 |  |  | $ | 24.92 |  |  | $ | 26.71 |  |  | $ | 18.15 |
Expected Volatility | 42.20 | % |  | 42.24 | % |  | 43.08 | % |  | 51.23 | %
Risk-Free Interest Rate | 0.89 | % |  | 0.50 | % |  | 1.33 | % |  | 0.07 | %
Dividend Yield | 3.28 | % |  | 2.25 | % |  | 2.88 | % |  | 2.88 | %
Expected Life | 5.3 years |  | 5.2 years |  | 0.5 years |  | 0.5 years
Schedule of Stock Options and SARs Transactions | The following table sets forth stock option and SAR transactions for the nine-month periods ended September 30, 2022 and 2021 (stock options and SARs in thousands):
| Nine Months Ended September 30, 2022 |  | Nine Months Ended September 30, 2021
| Number of Stock Options/SARs |  | Weighted Average Exercise Price |  | Number of Stock Options/SARs |  | Weighted Average Exercise Price
Outstanding at January 1 | 9,969 |  |  | $ | 84.37 |  |  | 10,186 |  |  | $ | 84.08 |
Granted | 2 |  |  | 97.64 |  |  | 1,976 |  |  | 81.66 |
Exercised (1) | (4,282) |  |  | 91.63 |  |  | (448) |  |  | 64.18 |
Forfeited | (192) |  |  | 84.26 |  |  | (984) |  |  | 98.64 |
Outstanding at September 30 (2) | 5,497 |  |  | $ | 78.73 |  |  | 10,730 |  |  | $ | 83.13 |
Vested or Expected to Vest (3) | 5,344 |  |  | $ | 79.05 |  |  | 10,407 |  |  | $ | 83.65 |
Exercisable at September 30 (4) | 3,686 |  |  | $ | 84.18 |  |  | 6,906 |  |  | $ | 92.39 |
(1)The total intrinsic value of stock options/SARs exercised during the nine months ended September 30, 2022 and 2021 was $122 million and $8 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the exercise price of the stock options/SARs. (2)The total intrinsic value of stock options/SARs outstanding at September 30, 2022 and 2021 was $194 million and $95 million, respectively. At both September 30, 2022 and 2021, the weighted average remaining contractual life was 4.3 years. (3)The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2022 and 2021 was $187 million and $90 million, respectively. At both September 30, 2022 and 2021, the weighted average remaining contractual life was 4.3 years. (4)The total intrinsic value of stock options/SARs exercisable at September 30, 2022 and 2021 was $114 million and $38 million, respectively. At September 30, 2022 and 2021, the weighted average remaining contractual life was 3.7 years and 3.2 years, respectively.
Schedule of Restricted Stock and Restricted Stock Unit Transactions | The following table sets forth restricted stock and restricted stock unit transactions for the nine-month periods ended September 30, 2022 and 2021 (shares and units in thousands):
| Nine Months Ended September 30, 2022 |  | Nine Months Ended September 30, 2021
| Number of Shares and Units |  | Weighted Average Grant Date Fair Value |  | Number of Shares and Units |  | Weighted Average Grant Date Fair Value
Outstanding at January 1 | 4,680 |  |  | $ | 69.37 |  |  | 4,742 |  |  | $ | 74.97 |
Granted | 1,623 |  |  | 113.03 |  |  | 1,409 |  |  | 81.44 |
Released (1) | (1,953) |  |  | 82.05 |  |  | (1,321) |  |  | 101.63 |
Forfeited | (130) |  |  | 65.44 |  |  | (65) |  |  | 68.49 |
Outstanding at September 30 (2) | 4,220 |  |  | $ | 80.41 |  |  | 4,765 |  |  | $ | 69.58 |
(1)The total intrinsic value of restricted stock and restricted stock units released during the nine months ended September 30, 2022 and 2021 was $215 million and $104 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. (2)The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2022 and 2021 was $472 million and $383 million, respectively.
Schedule of Performance Award Transactions | The following table sets forth the Performance Unit transactions for the nine-month periods ended September 30, 2022 and 2021 (units in thousands):
| Nine Months Ended September 30, 2022 |  | Nine Months Ended September 30, 2021
| Number of Units |  | Weighted Average Grant Date Fair Value |  | Number of Units |  | Weighted Average Grant Date Fair Value
Outstanding at January 1 | 679 |  |  | $ | 84.97 |  |  | 613 |  |  | $ | 88.38 |
Granted | 122 |  |  | 126.55 |  |  | 222 |  |  | 90.94 |
Granted for Performance Multiple (1) | — |  |  | — |  |  | 19 |  |  | 113.81 |
Released (2) | (57) |  |  | 136.74 |  |  | (175) |  |  | 113.06 |
Forfeited for Performance Multiple (3) | (56) |  |  | 136.74 |  |  | — |  |  | — |
Outstanding at September 30 (4) | 688 |  | (5) | $ | 83.82 |  |  | 679 |  |  | $ | 83.59 |
(1)Upon completion of the Performance Period for the Performance Units granted in 2017, a performance multiple of 125% was applied to the grants resulting in an additional grant of Performance Units in February 2021. (2)The total intrinsic value of Performance Units released was $7 million and $13 million for the nine months ended September 30, 2022 and 2021, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the Performance Units are released. (3)Upon completion of the Performance Period for the Performance Units granted in 2018, a performance multiple of 50% was applied to the grants resulting in a forfeiture of Performance Units in February 2022. (4)The total intrinsic value of Performance Units outstanding at September 30, 2022 and 2021 was approximately $77 million and $55 million, respectively. (5)Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of zero and a maximum of 1,376 Performance Units could be outstanding.

X
- Definition Performance Units and Performance Stock Grants Weighted Average Fair Values and Valuation Assumptions [Table Text Block] + References No definition available. + Details
Name: | eog_PerformanceUnitsandPerformanceStockGrantsWeightedAverageFairValuesandValuationAssumptionsTableTextBlock
Namespace Prefix: | eog_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -URI http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration